JTEC First Quarter 2025 Earnings: JP¥17.86 loss per share (vs JP¥12.60 loss in 1Q 2024)

Simply Wall St

November 16, 2024

JTEC (TSE:3446) First Quarter 2025 Results

Key Financial Results

Revenue: JP¥232.0m (down 22% from 1Q 2024).
Net loss: JP¥105.0m (loss widened by 42% from 1Q 2024).
JP¥17.86 loss per share (further deteriorated from JP¥12.60 loss in 1Q 2024).

earnings-and-revenue-growth — TSE:3446 Earnings and Revenue Growth November 16th 2024

All figures shown in the chart above are for the trailing 12 month (TTM) period

JTEC Earnings Insights

Looking ahead, revenue is forecast to grow 23% p.a. on average during the next 3 years, compared to a 6.5% growth forecast for the Medical Equipment industry in Japan.

Performance of the Japanese Medical Equipment industry.

The company's shares are down 16% from a week ago.

Risk Analysis

We should say that we've discovered 3 warning signs for JTEC (1 is potentially serious!) that you should be aware of before investing here.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.